Citadel Advisors - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$9,090
-52.2%
14,607
+28.4%
0.00%
Q2 2022$19,000
-94.3%
11,380
-88.4%
0.00%
Q4 2021$336,00098,0460.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,054,400$1,255,0001.58%
Quantum Private Wealth, LLC 10,000$11,0000.01%
Warberg Asset Management LLC 19,012$23,0000.00%
OSAIC HOLDINGS, INC. 600$1,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$120,0000.00%
WELLS FARGO & COMPANY/MN 58$00.00%
NORTHERN TRUST CORP 15,221$18,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,223$78,0000.00%
MORGAN STANLEY 1,066$1,0000.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders